The Patent Finder

Biogen, Inc.

Also on record
Records under this name other than the patents Biogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Biogen, Inc.

PatentTitleStatus Expires Confidence
US 7,635,466DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,198,955Method for Reducing Flu-Like Symptoms Associated with Intramuscular Administration of Interferon Using a Fast Titration Escalating Dosing Regimen
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,500,254Method for Reducing Flu-Like Symptoms Associated with Intramuscular Administration of Interferon Using a Fast Titration Escalating Dosing Regimen
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,450,379Method for Treating Joint Damage
Term ended
Term ended Nov 14, 2026 · High confidence
Term endedTerm ended Nov 14, 2026High confidence
US 10,654,940Method for Treating Joint Damage
Term ended
Term ended Nov 14, 2026 · High confidence
Term endedTerm ended Nov 14, 2026High confidence
US 7,588,755DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides
Formerly held
In force
Term ended Sep 15, 2026 · From the USPTO record
In forceTerm ended Sep 15, 2026From the USPTO record
US 7,759,117Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
Term ended
Term ended Feb 6, 2026 · From the USPTO record
Term endedTerm ended Feb 6, 2026From the USPTO record
US 11,192,856Process for preparing alpha-carboxamide pyrrolidine derivatives
Lapsed on the fee record
Ended Dec 7, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 7, 2025From the USPTO record
US 11,149,039Process for preparing spiro derivatives
Lapsed on the fee record
Ended Oct 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 19, 2025From the USPTO record
US 9,545,086BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders
Formerly held
Term ended
Term ended Jun 28, 2025 · Medium confidence
Term endedTerm ended Jun 28, 2025Medium confidence
10 of 283 patents shown.
Pro members see all 283.
Pro members: see all 283 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited